Structured evidence table for Selenium Sleep Onset Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Selenium Sleep Onset Randomized Trial | Moreover, taking such drugs during Ramadan has been reported to increase the risk of cerebral venous thrombosis [], and psychological resistance remains a major global challenge []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Selenium Sleep Onset Randomized Trial | For instance, Ahmadi reported that zinc supplementation reduced PMD symptoms [], and Tartagni reported the same for vitamin D []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Selenium Sleep Onset Randomized Trial | As summarized by Carlini, there is insufficient evidence to recommend improvements through interventions with a single nutrient []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Selenium Sleep Onset Randomized Trial | 1 2 3 4 5 Premenstrual disorder (PMD) is a serious issue for women across cultures, and is a comprehensive concept encompassing both physical and mental symptoms []. | 2 | Iimura Jun (2026) | Novel dietary FemTech based on dietary reference intakes for premenstrual and menstrual disorders: a pilot open-label randomized controlled trial of dietary intervention |
| Selenium Sleep Onset Randomized Trial | Interventions initiated preclinically or at the earliest disease stages, such as lifestyle modification, risk factor management, and cognitive support, could potentially alter AD trajectory, lowering incidence, delaying onset, and mitigating its multifaceted impact. | 4 | Han Mingfeng (2026) | The mechanisms and strategies for Alzheimer’s disease prevention: An update |
| Selenium Sleep Onset Randomized Trial | We focus specifically on translating prevention evidence into actionable strategies for at-risk populations. | 4 | Han Mingfeng (2026) | The mechanisms and strategies for Alzheimer’s disease prevention: An update |
| Selenium Sleep Onset Randomized Trial | By consolidating this evidence, our goals are threefold: to inform public health policy, to guide future research priorities, and to support clinical practices aimed at preemptive management. | 4 | Han Mingfeng (2026) | The mechanisms and strategies for Alzheimer’s disease prevention: An update |
| Selenium Sleep Onset Randomized Trial | , , Alzheimer’s disease (AD) represents a profound challenge in neurodegenerative medicine, characterized by progressive cognitive decline and complex pathophysiology. | 4 | Han Mingfeng (2026) | The mechanisms and strategies for Alzheimer’s disease prevention: An update |
Source documents